Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Le Travenues Technology Limited Capital/Financing Update 2025

Nov 12, 2025

59593_rns_2025-11-12_1221141f-85c1-473e-8441-9c955f050ca6.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [71 x 34] intentionally omitted <==

November 12, 2025 LTTL/L&S/2025-26/11/19

To, The Listing Department, The Listing Department, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C - 1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai - 400 051 Mumbai - 400 001 Maharashtra, India Maharashtra, India

Dear Sir / Madam,

Sub : Outcome of the Board Meeting under Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) - Regulations, 2015 Allotment of equity shares and setting up of a wholly owned subsidiary in Singapore

Ref : Le Travenues Technology Limited (ISIN: INE0HV901016) NSE Symbol: IXIGO and BSE Scrip Code: 544192

In compliance with Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “ SEBI Listing Regulations ”), please note that the board of directors (the “ Board ”) of Le Travenues Technology Limited (the “ Company ”) at its meeting held today, i.e., November 12, 2025, inter-alia, considered and approved, the following:

  1. Allotment of 46,270,092 (Four Crore Sixty Two Lakhs Seventy Thousand Ninety Two) equity shares of face value of ₹1 (Rupee One only) each (“ Equity Shares ”), for cash at an issue price of ₹280 (Rupees Two Hundred Eighty only) per Equity Share, including a premium of ₹279 (Rupees Two Hundred Seventy-Nine only) per share, aggregating to ₹12,955,625,760 (Rupees One Thousand Two Hundred Ninety Five Crore Fifty Six Lakh Twenty Five Thousand Seven Hundred Sixty only) representing 10.10% (Ten Point One Percent) of the post preferential issue paid-up equity share capital (on a fully-diluted basis including vested, unvested and unallocated options under the prevailing employee stock option schemes) of the Company, by way of preferential issue on private placement basis to MIH Investments One B.V. (“ Investor ”) in accordance with the provisions of the Companies Act, 2013 and rules made thereunder, Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“ SEBI ICDR Regulations ”), each as amended, and other applicable laws (“ Preferential Issue ”). Consequent to the said allotment, the paid-up share capital of the Company increased from ₹390,403,607/- to ₹436,673,699/-.

The requisite details pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is enclosed herewith in Annexure A .

  1. Allotment of 905,489 (Nine Lakhs Five Thousand Four Hundred and Eighty Nine) fully paid up equity shares having a face value of ₹1/- (Rupee One only) each pursuant to

==> picture [374 x 75] intentionally omitted <==

==> picture [71 x 34] intentionally omitted <==

the exercise of stock options under Le Travenues Technology - Employees Stock Option Scheme 2012 (“ ESOS 2012 ”), Le Travenues Technology - Employees Stock Option Scheme 2013 (“ ESOS 2013 ”), Le Travenues Technology - Employees Stock Option Scheme 2016 (“ ESOS 2016 ”), Le Travenues Technology - Employees Stock Option Scheme 2020 (“ ESOS 2020 ”), Le Travenues Technology - Employees Stock Option Scheme 2021 (“ ESOS 2021 ”) and Le Travenues Technology - Employees Stock Option Scheme 2024 (“ ESOS 2024 ”), by the option holders. Consequent to the said allotment, the paid-up share capital of the Company increased from ₹436,673,699/- to ₹437,579,188/-.

The requisite details pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, are set out in Annexure B and Annexure C, respectively.

  1. Setting up of a wholly owned subsidiary in Singapore under the name and style of ‘IXIGO PTE. LTD.’ or such other name as may be deemed appropriate or may be available and approved by the Accounting and Corporate Regulatory Authority, Singapore.

The requisite details pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, are enclosed herewith in Annexure D.

The meeting commenced at 03:00 P.M. (IST) and concluded at 03:30 P.M. (IST).

This announcement will also be available on the website of the Company at https://investors.ixigo.com/.

This is for your information and records.

Thank you,

For Le Travenues Technology Limited

SURESH KUMAR Digitally signed by SURESH KUMAR BHUTANI BHUTANI Date: 2025.11.12 15:32:36 +05'30'

Suresh Kumar Bhutani (Group General Counsel, Company Secretary & Compliance Officer)

==> picture [374 x 75] intentionally omitted <==

==> picture [71 x 34] intentionally omitted <==

Annexure A

Details of the allotment of equity shares by way of Preferential Issue

S. No. Disclosures Particulars Particulars
1. Type of securities
proposed to be
issued		 Equity Shares of face value of ₹1/- each
2. Type of issuance Preferential allotment
3. Total number of
securities proposed
to be issued or the
total amount for
which the securities
will be issued
(approximately)		 Allotment of 46,270,092 equity shares of the Company
of face value of ₹1 (Rupee One only) each, for cash, at
an issue price of ₹280 (Rupees Two Hundred Eighty
only) per equity share, aggregating to ₹12,955,625,760
(Rupees One Thousand Two Hundred Ninety Five Crore
Fifty Six Lakh Twenty Five Thousand Seven Hundred
Sixty only) being 10.10% (Ten Point One Percent) of the
post preferential issue paid-up equity share capital (on a
fully-diluted basis including vested, unvested and
unallocated options under the prevailing employee stock
option schemes) of the Company.
4. Additional details in case of Preferential Issue:
Name of the Investor MIH Investments One B.V. (“Investor”)
Post allotment of
securities - outcome
of the subscription,
issue price / allotted
price (in case of
convertibles),
number of investors		 Details of the shareholding of the Investor in the
Company, prior to and after the Preferential Issue, are as
under:
Name of the
Investor
Pre-issue
shareholding
Post preferential issue
shareholding
No. of
shares
%
No. of
shares
%
MIH
Investments
One B.V.
20,805,839
5.05%
67,075,931
14.64%
*The pre and post preferential issue shareholding are on a fully
diluted basis including vested, unvested and unallocated options
under the prevailing employee stock option schemes.
Issue Price:₹280 (Rupees Two Hundred Eighty only)
per equity share
Number of investors/allottee:**1 (one)
In case of
convertibles -
intimation on
conversion of
securities or on lapse
of the tenure of the
instrument		 Not applicable

==> picture [374 x 75] intentionally omitted <==

==> picture [71 x 34] intentionally omitted <==

Annexure B

Details with respect to allotment of equity shares pursuant to the exercise of stock options under Employees Stock Option Schemes

S. No. Disclosures Particulars Particulars
A. Brief
details
of
options
granted		 The present disclosure is in relation to the allotment
of 905,489 equity shares upon exercise of vested
options by the option holders under ESOS 2012,
ESOS 2013, ESOS 2016, ESOS 2020, ESOS 2021
and ESOS 2024.
B. Whether the scheme is in
terms
of
SEBI
(Share
Based Employee Benefits
and
Sweat
Equity)
Regulations,
2021
(if
applicable)		 Yes
C. Total number of shares
covered by these options		 The present disclosure is in relation to the allotment
of 905,489 equity shares upon exercise of vested
options by the option holders under ESOS 2012,
ESOS 2013, ESOS 2016, ESOS 2020, ESOS 2021
and ESOS 2024.
D. Pricing formula Exercise price of the shares will be the fair market
value of the shares, the fair market value will be the
closing price of the share on the stock exchange
having the highest trading volume of shares, as on
the trading date immediately prior to the date of the
Board / Compensation Committee meeting wherein
the Grants of Options will be approved. The Board /
Compensation Committee has a power to provide
suitable discount or charge premium on such price as
arrived above including the power to Grant Options
at par value. However, in any case the Exercise Price
shall not go below the par value of Equity Share of
the Company.
E. Options vested The total number of remaining vested options as of
November 12, 2025, after the present allotment
under the relevant employee stock option schemes
are as follows:
Scheme
No. of Vested Options
ESOS 2012
84,136
ESOS 2013
401,039
ESOS 2016
316,570
ESOS 2020
245,075
ESOS 2021
2,070,279
Scheme No. of Vested Options
ESOS 2012 84,136
ESOS 2013 401,039
ESOS 2016 316,570
ESOS 2020 245,075
ESOS 2021 2,070,279

==> picture [374 x 75] intentionally omitted <==

==> picture [71 x 34] intentionally omitted <==

S. No. Disclosures Particulars Particulars
ESOS 2024 405,303
F. Time within which option
may be exercised		 The exercise period for the vested options will be
determined by the Committee at the time of grant
which shall be a maximum of five years after vesting
of the last tranche of Options granted to the
respective employee, beyond which the Options
would lapse.
G. Options exercised 905,489 Options
H. Money realized by exercise
of options		 ₹2,592,980/-
I. The total number of shares
arising
as
a
result
of
exercise of option		 905,489 Equity Shares
J. Options lapsed The total number of options lapsed till November 12,
2025, under the relevant employee stock option
schemes are as follows:
Scheme
No. of Lapsed Options
ESOS 2012
4,978,464
ESOS 2013
14,852,143
ESOS 2016
3,255,429
ESOS 2020
691,618
ESOS 2021
3,246,953
ESOS 2024
72,244
The number of lapsed options are since the
inception of the respective schemes. Lapsed options
were added back to the pool and were eligible for
regrant under the respective schemes.
K. Variation of terms of options During the year under review, there is no variation of
the terms of options.
L. Brief details of significant
terms		 The objectives of schemes are as follows:
•To motivate and retain talented employees to
contribute towards the overall growth and
profitability of the Company;
•To provide means to enable the Company to
attract and retain appropriate human talent in the
employment of the Company;
•To achieve sustained growth and the creation of
shareholder value by aligning the interests of the
employees with the long-term interests of the
Company;

==> picture [374 x 75] intentionally omitted <==

==> picture [71 x 34] intentionally omitted <==

S. No. Disclosures Particulars
•To create a sense of ownership and participation
amongst the employees to share the value they
create for the Company in the years to come; and
•To provide additional deferred rewards to
employees.
M. Subsequent
changes
or
cancellation or exercise of
such options		 Upon exercise, the vested options are converted into
an equivalent number of equity shares on a_pari_
_passu_basis with the existing equity shares of the
Company.
N. Diluted earnings per share
pursuant to issue of equity
shares
on
exercise
of
options		 The disclosure related to diluted earnings per share
pursuant to issue of equity shares on exercise of
options will be submitted along with the financial
results in compliance with Regulation 33 of the SEBI
(Listing Obligations and Disclosure Requirements)
Regulations, 2015.

==> picture [374 x 75] intentionally omitted <==

==> picture [71 x 34] intentionally omitted <==

Annexure C

Details pursuant to Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

S. No. Disclosures Particulars Particulars Particulars
A. Company
name
and
address
of
Registered
Office		 Le Travenues Technology Limited
Second Floor, Veritas Building, Sector - 53, Golf
Course Road, Gurugram - 122 002, Haryana,
India
B. Name
of
the
Stock
Exchanges on which the
company’s
shares
are
listed		 BSE Limited (“BSE”)
National Stock Exchange of India Limited (“NSE”)
C. Filing date of the statement
referred in regulation 10(b)
of the SEBI (Share Based
Employee
Benefits
and
Sweat Equity) Regulations,
2021 with Stock Exchange		 Filing Date
October 29, 2024
October 22, 2024
October 15, 2024
November 04, 2024
July 24, 2024 &
October 09, 2024
October 04, 2024
Scheme Filing Date
ESOS 2012 October 29, 2024
ESOS 2013 October 22, 2024
ESOS 2016 October 15, 2024
ESOS 2020 November 04, 2024
ESOS 2021 July 24, 2024 &
October 09, 2024
ESOS 2024 October 04, 2024
D. Filing Number, if any Number
NSE
44983
44810
44669
45064
42959 &
44578
44466
Scheme Filing Number
BSE NSE
ESOS 2012 215083 44983
ESOS 2013 214525 44810
ESOS 2016 206901 44669
ESOS 2020 215321 45064
ESOS 2021 207104 &
206899		 42959 &
44578
ESOS 2024 213273 44466
E. Title
of
the
Scheme
pursuant to which shares
are issued, if any		 1. Le Travenues Technology - Employees
Stock Option Scheme 2012;
2. Le Travenues Technology - Employees
Stock Option Scheme 2013;
3. Le Travenues Technology - Employees
Stock Option Scheme 2016;
4. Le Travenues Technology - Employees
Stock Option Scheme 2020;
5. Le Travenues Technology - Employees
Stock Option Scheme 2021; and
6. Le Travenues Technology - Employees
Stock Option Scheme 2024

==> picture [374 x 75] intentionally omitted <==

==> picture [71 x 34] intentionally omitted <==

S. No. Disclosures Particulars Particulars
F. Kind of security to be listed Equity Shares
G. Par value of the shares ₹1/-per equity share
H. Date of issue of shares November 12, 2025
I. Number of shares issued 905,489 equity shares
J. Share Certificate No., if
applicable		 N.A.
K. Distinctive number of the
share, if applicable		 436677864 - 437583352
L. ISIN Number of the shares
if issued in Demat		 INE0HV901016
M. Exercise price per share No. of shares
346,194
145,745
109,286
18,200
270,139
15,925
Scheme Exercise
Price (₹)		 No. of shares
ESOS 2012 1.25 346,194
ESOS 2013 1.25 145,745
ESOS 2016 1.25 109,286
ESOS 2020 1.25 18,200
ESOS 2021 1.25 270,139
ESOS 2024 93.00 15,925
N. Premium per share No. of shares
346,194
145,745
109,286
18,200
270,139
15,925
Scheme Premium per
share (₹)		 No. of shares
ESOS 2012 0.25 346,194
ESOS 2013 0.25 145,745
ESOS 2016 0.25 109,286
ESOS 2020 0.25 18,200
ESOS 2021 0.25 270,139
ESOS 2024 92.00 15,925
O. Total issued shares after
this issue		 437,579,188
P. Total issued share capital
after this issue		 ₹437,579,188/-
Q. Details of any lock-in on the
shares		 N.A.
R. Date of expiry of lock-in N.A.
S. Whether shares identical in
all respects to existing
shares if not, when will they
become identical?		 The equity shares allotted pursuant to exercise of
options shall rank_pari passu_with the existing
shares of the Company.
T. Details of listing fees, if
payable		 N.A.

==> picture [374 x 75] intentionally omitted <==

==> picture [71 x 34] intentionally omitted <==

Annexure - D

Details for wholly owned subsidiary proposed to be incorporated in Singapore

S. No. Disclosures Particulars
A. Name of the entity
Date of incorporation
Country of incorporation,
etc.		 IXIGO PTE. LTD. or such other name as may be
deemed appropriate or may be available and
approved by the Accounting and Corporate
Regulatory Authority, Singapore.
Not applicable, the entity is proposed to be
incorporated.
Singapore
B. Name of holding company
of the incorporated
company and relation with
the listed entity		 Le Travenues Technology Limited (the listed
entity) will be the holding company of the wholly
owned subsidiary proposed to be incorporated in
Singapore.
C. Industry to which the entity
being incorporated belongs		 Travel Technology and Strategic Investment
Management
D. Brief background about the
entity incorporated in terms
of
products
/
line
of
business		 The proposed entity is planned to be
incorporated in Singapore to lead investment and
strategic management initiatives, with an
emphasis on fostering the Group’s international
expansion and strengthening business synergies
across key markets.
E. Brief details of any
governmental or regulatory
approvals required for the
incorporation		 The incorporation of the proposed entity will be
carried out in accordance with the applicable laws
and regulations of Singapore, including the
Companies Act and other relevant statutory
requirements. The Company will also comply with
applicable Indian laws, including the Companies
Act, 2013 and the Foreign Exchange Management
Act along with its Rules, Regulations, and
Directions issued by the Reserve Bank of India, as
well as any other applicable foreign exchange and
investment regulations, while investing funds for
setting up of a wholly owned subsidiary in
Singapore.
F. Nature of consideration -
whether cash consideration
or share swap and details
of the same		 Cash consideration. The Board has granted the
approval for setting up of a wholly owned
subsidiary in Singapore with an initial investment
of Indian Rupees equivalent to SGD 50,000.

==> picture [374 x 75] intentionally omitted <==

==> picture [71 x 34] intentionally omitted <==

G. Cost of subscription / price
at which the shares are
subscribed		 The Board has granted the approval for setting
up of a wholly owned subsidiary in Singapore
with an initial investment of Indian Rupees
equivalent to SGD 50,000.
Subject to compliance with the applicable laws of
Singapore, the proposed initial investment will be
at par (i.e., the nominal value of the share(s)
issued at incorporation).
H. Percentage of
shareholding / control by
the listed entity and / or
number of shares allotted.		 Le Travenues Technology Limited will hold the
entire share capital of the wholly owned subsidiary
proposed to be incorporated in Singapore.

==> picture [374 x 75] intentionally omitted <==

More from Le Travenues Technology Limited

Regulatory Filings 2026
Jun 1
Regulatory Filings 2026
Jun 1
Call Transcript 2026
May 29
Call Transcript 2026
May 29
Regulatory Filings 2026
May 28
Regulatory Filings 2026
May 28
Regulatory Filings 2026
May 27
Regulatory Filings 2026
May 27
Regulatory Filings 2026
May 25
Regulatory Filings 2026
May 25
View all filings →